Precigen, Inc. (PGEN) has a negative trailing P/E of -5.0, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 26.4 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -19.82%, forward earnings yield 3.79%. PEG 0.29 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
Overall SharesGrow Score: 47/100 with 2/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2016 | -15.2 | -0.14 | 5.07 | 14.86 | - |
| 2017 | -11.8 | 0.31 | 2.59 | 5.98 | - |
| 2018 | -1.7 | -0.01 | 2.33 | 5.28 | - |
| 2019 | -5.0 | 0.08 | 11.78 | 26.40 | - |
| 2020 | -10.0 | 0.41 | 25.37 | 53.27 | - |
| 2021 | -8.0 | 0.15 | 6.83 | 51.43 | - |
| 2022 | 10.8 | -0.36 | 2.41 | 11.32 | - |
| 2023 | -3.4 | -0.19 | 2.77 | 52.64 | - |
| 2024 | -2.4 | -0.12 | 7.79 | 76.40 | - |
| 2025 | -5.1 | -0.03 | 60.91 | 131.52 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2016 | $-1.58 | $190.93M | $-186.61M | -97.7% |
| 2017 | $-0.98 | $230.98M | $-117.02M | -50.7% |
| 2018 | $-3.93 | $160.57M | $-509.34M | -317.2% |
| 2019 | $-1.35 | $90.72M | $-207.76M | -229% |
| 2020 | $-0.62 | $103.18M | $-103.77M | -100.6% |
| 2021 | $-0.49 | $103.87M | $-96.77M | -93.2% |
| 2022 | $-0.40 | $26.91M | $-79.78M | -296.5% |
| 2023 | $-0.39 | $6.23M | $-95.9M | -1540.6% |
| 2024 | $-0.47 | $3.93M | $-126.24M | -3216.2% |
| 2025 | $-1.41 | $9.68M | $-250.64M | -2588.2% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $-0.05 | $-0.14 – $0.05 | $115.44M | $101.54M – $129.34M | 2 |
| 2027 | $0.15 | $0.12 – $0.18 | $209M | $190.9M – $227.09M | 2 |
| 2028 | $0.44 | $0.34 – $0.53 | $319.82M | $266.09M – $371.69M | 1 |
| 2029 | $0.69 | $0.54 – $0.84 | $435.94M | $362.7M – $506.65M | 1 |
| 2030 | $1.02 | $0.80 – $1.24 | $580.46M | $482.93M – $674.61M | 1 |
